Skip to content
10-Q

Quarterly Report

Metagenomi Therapeutics, Inc. MGX

0000950170-25-107308

← back to feed
Filed
Aug 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 5, 2025 37.53M sh
Shares Diluted Q2 2025 · Jun 30, 2025 37.16M sh
Shares Diluted Q2 2025 · Jun 30, 2025 37.09M sh
Shares Diluted Q2 2025 · Jun 30, 2024 36.63M sh
Shares Diluted Q2 2025 · Jun 30, 2024 28.9M sh
Capex Q2 2025 · Jun 30, 2025 $415K
Capex Q2 2025 · Jun 30, 2024 $1.58M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$44.09M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$56.16M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $26.85M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $27.39M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $61.18M
Stockholders Equity Q2 2025 · Jun 30, 2025 $195.83M
Stockholders Equity Q2 2025 · Mar 31, 2025 $212.66M
Stockholders Equity Q2 2025 · Dec 31, 2024 $234.86M
Stockholders Equity Q2 2025 · Jun 30, 2024 $269.42M
Stockholders Equity Q2 2025 · Mar 31, 2024 $275.63M
Stockholders Equity Q2 2025 · Dec 31, 2023 −$135.58M
Current Liabilities Q2 2025 · Jun 30, 2025 $33.27M
Current Liabilities Q2 2025 · Dec 31, 2024 $37.31M
Total Liabilities Q2 2025 · Jun 30, 2025 $76.45M
Total Liabilities Q2 2025 · Dec 31, 2024 $89.74M
Current Assets Q2 2025 · Jun 30, 2025 $211.68M
Current Assets Q2 2025 · Dec 31, 2024 $257.96M
Total Assets Q2 2025 · Jun 30, 2025 $272.28M
Total Assets Q2 2025 · Dec 31, 2024 $324.6M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.54
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.21
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.29
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.24
Eps Basic Q2 2025 · Jun 30, 2025 −$0.54
Eps Basic Q2 2025 · Jun 30, 2025 −$1.21
Eps Basic Q2 2025 · Jun 30, 2024 −$0.29
Eps Basic Q2 2025 · Jun 30, 2024 −$1.24
Sga Expense Q2 2025 · Jun 30, 2025 $6.99M
Sga Expense Q2 2025 · Jun 30, 2025 $13.8M
Sga Expense Q2 2025 · Jun 30, 2024 $8.55M
Sga Expense Q2 2025 · Jun 30, 2024 $17.3M
Rd Expense Q2 2025 · Jun 30, 2025 $22.51M
Rd Expense Q2 2025 · Jun 30, 2025 $47.65M
Rd Expense Q2 2025 · Jun 30, 2024 $28.32M
Rd Expense Q2 2025 · Jun 30, 2024 $59.76M
Net Income Q2 2025 · Jun 30, 2025 −$19.91M
Net Income Q2 2025 · Jun 30, 2025 −$44.95M
Net Income Q2 2025 · Mar 31, 2025 −$25.04M
Net Income Q2 2025 · Jun 30, 2024 −$10.74M
Net Income Q2 2025 · Jun 30, 2024 −$35.89M
Net Income Q2 2025 · Mar 31, 2024 −$25.15M
Operating Income Q2 2025 · Jun 30, 2025 −$20.99M
Operating Income Q2 2025 · Jun 30, 2025 −$48.81M
Operating Income Q2 2025 · Jun 30, 2024 −$16.86M
Operating Income Q2 2025 · Jun 30, 2024 −$45.9M
Revenue Q2 2025 · Jun 30, 2025 $8.51M
Revenue Q2 2025 · Jun 30, 2025 $12.64M
Revenue Q2 2025 · Jun 30, 2024 $20.01M
Revenue Q2 2025 · Jun 30, 2024 $31.17M